Reading Time: 3 minutesIntroduction Alzheimer's disease represents a significant public health challenge, particularly among American males, where it is a leading cause of dementia. This neurodegenerative disorder progressively impairs cognitive function, affecting memory, thinking, and behavior. Recent research has pivoted towards exploring pharmacological interventions that may mitigate these effects. Among these, Serostim, a recombinant human growth hormone, has been investigated for its potential cognitive benefits. This article delves into a comprehensive longitudinal study conducted over a decade, focusing on the neurological outcomes and patient experiences of American males with Alzheimer's disease treated with Serostim. Study Design and Methodology The study involved a cohort … Continue reading →